[Show abstract][Hide abstract] ABSTRACT: We have reported a case series of five patients with jaw-opening oromandibular dystonia secondary to Wilson's disease (WD), in which the patients were treated with botulinum toxin type A (BTX-A). In all cases, dystonia score was partially reduced three weeks after injections. The most common side effect was transient mild dysphagia. This preliminary study showed that jaw-opening oromandibular dystonia in WD may be partially responsive to the use of BTX-A.
Arquivos de neuro-psiquiatria 06/2012; 70(6):407-9. DOI:10.1590/S0004-282X2012000600005 · 0.84 Impact Factor